CVKDClinical Trials•businesswire•
Cadrenal Therapeutics Announces Clinical Trial Initiation Plans for Tecarfarin in Patients with End-Stage Kidney Disease (ESKD) Transitioning to Dialysis
Sentiment:Neutral (40)
Summary
PONTE VEDRA, Fla.--(BUSINESS WIRE)---- $CVKD #AFib--Cadrenal announces clinical trial initiation plans for tecarfarin in patients with end-stage kidney disease (ESKD) who are transitioning to dialysis
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 5, 2025 by businesswire